Literature DB >> 23707062

H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation.

Cristian Bellodi1, Mary McMahon, Adrian Contreras, Dayle Juliano, Noam Kopmar, Tomoka Nakamura, David Maltby, Alma Burlingame, Sharon A Savage, Akiko Shimamura, Davide Ruggero.   

Abstract

Noncoding RNAs control critical cellular processes, although their contribution to disease remains largely unexplored. Dyskerin associates with hundreds of H/ACA small RNAs to generate a multitude of functionally distinct ribonucleoproteins (RNPs). The DKC1 gene, encoding dyskerin, is mutated in the multisystem disorder X-linked dyskeratosis congenita (X-DC). A central question is whether DKC1 mutations affect the stability of H/ACA RNPs, including those modifying ribosomal RNA (rRNA). We carried out comprehensive profiling of dyskerin-associated H/ACA RNPs, revealing remarkable heterogeneity in the expression and function of subsets of H/ACA small RNAs in X-DC patient cells. Using a mass spectrometry approach, we uncovered single-nucleotide perturbations in dyskerin-guided rRNA modifications, providing functional readouts of small RNA dysfunction in X-DC. In addition, we identified that, strikingly, the catalytic activity of dyskerin is required for accurate hematopoietic stem cell differentiation. Altogether, these findings reveal that small noncoding RNA dysfunctions may contribute to the pleiotropic manifestation of human disease.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707062      PMCID: PMC3857015          DOI: 10.1016/j.celrep.2013.04.030

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  50 in total

Review 1.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

2.  Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; June A Peters; Jennifer T Loud; Lisa Leathwood; Ann G Carr; Mark H Greene; Philip S Rosenberg
Journal:  Br J Haematol       Date:  2010-04-30       Impact factor: 6.998

3.  The Cbf5-Nop10 complex is a molecular bracket that organizes box H/ACA RNPs.

Authors:  Tomoko Hamma; Steve L Reichow; Gabriele Varani; Adrian R Ferré-D'Amaré
Journal:  Nat Struct Mol Biol       Date:  2005-11-15       Impact factor: 15.369

4.  The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase.

Authors:  D L Lafontaine; C Bousquet-Antonelli; Y Henry; M Caizergues-Ferrer; D Tollervey
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

5.  Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.

Authors:  Andrew Yoon; Guang Peng; Yves Brandenburger; Yves Brandenburg; Ornella Zollo; Wei Xu; Eduardo Rego; Davide Ruggero
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

6.  Specific small nucleolar RNA expression profiles in acute leukemia.

Authors:  W Valleron; E Laprevotte; E-F Gautier; C Quelen; C Demur; E Delabesse; X Agirre; F Prósper; T Kiss; P Brousset
Journal:  Leukemia       Date:  2012-04-23       Impact factor: 11.528

7.  rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells.

Authors:  Karen Jack; Cristian Bellodi; Dori M Landry; Rachel O Niederer; Arturas Meskauskas; Sharmishtha Musalgaonkar; Noam Kopmar; Olya Krasnykh; Alison M Dean; Sunnie R Thompson; Davide Ruggero; Jonathan D Dinman
Journal:  Mol Cell       Date:  2011-11-18       Impact factor: 17.970

8.  Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.

Authors:  Luis F Z Batista; Matthew F Pech; Franklin L Zhong; Ha Nam Nguyen; Kathleen T Xie; Arthur J Zaug; Sharon M Crary; Jinkuk Choi; Vittorio Sebastiano; Athena Cherry; Neelam Giri; Marius Wernig; Blanche P Alter; Thomas R Cech; Sharon A Savage; Renee A Reijo Pera; Steven E Artandi
Journal:  Nature       Date:  2011-05-22       Impact factor: 49.962

9.  Aberrant 3' oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia.

Authors:  Christine Hilcenko; Paul J Simpson; Andrew J Finch; Frank R Bowler; Mark J Churcher; Li Jin; Len C Packman; Adam Shlien; Peter Campbell; Michael Kirwan; Inderjeet Dokal; Alan J Warren
Journal:  Blood       Date:  2012-11-27       Impact factor: 22.113

10.  The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma.

Authors:  D Ronchetti; K Todoerti; G Tuana; L Agnelli; L Mosca; M Lionetti; S Fabris; P Colapietro; M Miozzo; M Ferrarini; P Tassone; A Neri
Journal:  Blood Cancer J       Date:  2012-11-23       Impact factor: 11.037

View more
  58 in total

Review 1.  Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease.

Authors:  Mary McMahon; Adrian Contreras; Davide Ruggero
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-10-31       Impact factor: 9.957

Review 2.  Pathways to Specialized Ribosomes: The Brussels Lecture.

Authors:  Jonathan D Dinman
Journal:  J Mol Biol       Date:  2016-01-04       Impact factor: 5.469

3.  Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis.

Authors:  Eszter Balogh; Jennifer C Chandler; Máté Varga; Mona Tahoun; Dóra K Menyhárd; Gusztáv Schay; Tomas Goncalves; Renáta Hamar; Regina Légrádi; Ákos Szekeres; Olivier Gribouval; Robert Kleta; Horia Stanescu; Detlef Bockenhauer; Andrea Kerti; Hywel Williams; Veronica Kinsler; Wei-Li Di; David Curtis; Maria Kolatsi-Joannou; Hafsa Hammid; Anna Szőcs; Kristóf Perczel; Erika Maka; Gergely Toldi; Florentina Sava; Christelle Arrondel; Magdolna Kardos; Attila Fintha; Ahmed Hossain; Felipe D'Arco; Mario Kaliakatsos; Jutta Koeglmeier; William Mifsud; Mariya Moosajee; Ana Faro; Eszter Jávorszky; Gábor Rudas; Marwa H Saied; Salah Marzouk; Kata Kelen; Judit Götze; George Reusz; Tivadar Tulassay; François Dragon; Géraldine Mollet; Susanne Motameny; Holger Thiele; Guillaume Dorval; Peter Nürnberg; András Perczel; Attila J Szabó; David A Long; Kazunori Tomita; Corinne Antignac; Aoife M Waters; Kálmán Tory
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

Review 4.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

5.  H/ACA snoRNA levels are regulated during stem cell differentiation.

Authors:  Kathleen L McCann; Sanam L Kavari; Adam B Burkholder; Bart T Phillips; Traci M Tanaka Hall
Journal:  Nucleic Acids Res       Date:  2020-09-04       Impact factor: 16.971

Review 6.  Current insights into the diagnosis and treatment of inherited bone marrow failure syndromes in China.

Authors:  Xiaofan Zhu
Journal:  Stem Cell Investig       Date:  2015-08-06

Review 7.  Biology and clinical relevance of noncoding sno/scaRNAs.

Authors:  Thuy Cao; Sheeja Rajasingh; Saheli Samanta; Buddhadeb Dawn; Douglas C Bittel; Johnson Rajasingh
Journal:  Trends Cardiovasc Med       Date:  2017-08-12       Impact factor: 6.677

Review 8.  Heterogeneity and specialized functions of translation machinery: from genes to organisms.

Authors:  Naomi R Genuth; Maria Barna
Journal:  Nat Rev Genet       Date:  2018-07       Impact factor: 53.242

Review 9.  Non-coding RNAs and disease: the classical ncRNAs make a comeback.

Authors:  Rogerio Alves de Almeida; Marcin G Fraczek; Steven Parker; Daniela Delneri; Raymond T O'Keefe
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

Review 10.  Transcriptome-wide dynamics of RNA pseudouridylation.

Authors:  John Karijolich; Chengqi Yi; Yi-Tao Yu
Journal:  Nat Rev Mol Cell Biol       Date:  2015-08-19       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.